This is why patients are paying attention
Our review of the clinical trial pipeline reveals 39 new GLP-1 drugs in development from 34 companies, with only seven among the top 20 pharmaceutical companies
These risks highlight the importance of professional guidance
Kaufman reported that after embracing doctors and patients reports and launching the trial, RECOVER will be using far higher doses (0.1-.25mg vs 2.5 mg) in their long-COVID trial
The weight loss by Hers program is a holistic service that provides tools to help you better manage your weight with medical prescriptions as well as nutrition support, meal replacement options, activity goals and more
If you experience severe symptoms like persistent vomiting, severe abdominal pain, or signs of pancreatitis (intense upper abdominal pain radiating to the back), seek medical attention immediately